Sigachi Industries Q1 Results: Revenue ₹121.3 crore, EBITDA margin at 13.6%
Sigachi Industries posted Q1FY27 revenue of ₹121.27 crore and net profit of ₹8.14 crore. MCC realizations increased to ₹241.36/kg, and the company reaffirmed its full-year revenue guidance of ₹650-675 crore, expecting quarter-on-quarter growth.

*this image is generated using AI for illustrative purposes only.
Sigachi Industries reported total operating income of ₹121.27 crore for the first quarter of FY27, with net profit standing at ₹8.14 crore. The company’s EBITDA was ₹16.5 crore, reflecting a margin of 13.6%. Management reaffirmed its full-year revenue guidance of ₹650-675 crore, indicating that revenues are expected to rise quarter-on-quarter in the coming periods.
Financial Performance
The Microcrystalline Cellulose (MCC) segment contributed the largest share of revenue at ₹82.74 crore. The API segment recorded revenues of ₹21.68 crore, while the Operations & Maintenance (O&M) vertical contributed ₹13.06 crore. The CFO noted that fixed costs remain constant, which should support margin expansion as revenues increase.
| Segment | Revenue (₹ crore) |
|---|---|
| MCC | 82.74 |
| API | 21.68 |
| O&M | 13.06 |
| Total Operating Income | 121.27 |
Operational Highlights
Average realization for MCC rose to ₹241.36 per kg in Q1, up from ₹216 per kg in the previous quarter. Overall capacity utilization stood at 76.8%, with the Dahej unit at 76.5% and Jhagadia at 77.16%. Management indicated that utilization is expected to improve quarter-on-quarter through debottlenecking initiatives.
The company’s cellulose-based excipient capacity currently stands at 18,000 metric tons per annum, with exports accounting for over 53.5% of production. A planned 12,000 metric ton capacity expansion at Dahej-2 is on schedule for commissioning by Q2 of FY28, which will raise total capacity to 30,000 metric tons per annum.
Strategic Initiatives
Sigachi launched HiCel SMCC Nutra during the quarter, a combination product targeting flowability and compressibility challenges in nutraceutical formulations. The company also advanced its 1,800-ton Croscarmellose Sodium (CCS) facility at Dahej SEZ, aiming to strengthen its higher-value excipient portfolio.
Regarding working capital, receivable days are currently around 93-94 days, with management targeting a reduction to approximately 90 days by year-end and further down to 75-80 days subsequently.
What the Numbers Show
The MCC segment dominates the revenue mix, contributing roughly 68% of total operating income in Q1. This concentration highlights the importance of the upcoming Dahej-2 expansion; without it, the company relies heavily on debottlenecking existing facilities to meet its aggressive full-year revenue guidance of ₹650-675 crore. Additionally, the significant quarter-on-quarter jump in MCC realizations (from ₹216 to ₹241.36 per kg) suggests improving pricing power or a shift toward higher-value grades, which will be critical for achieving the guided 18% full-year EBITDA margin from the current 13.6% run rate.
Outlook and Guidance
Management confirmed no change to the full-year revenue guidance of ₹650-675 crore. Capex for FY27 is expected to exceed ₹100 crore, with an additional ₹150-200 crore planned for FY28. Funding options include bank finance and potential preferential equity issues. An insurance claim related to a previous incident is expected to be settled by September, either fully with a discount or as an ad-hoc amount.
Historical Stock Returns for Sigachi Industries
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +4.95% | +14.29% | +18.77% | +36.47% | -2.95% | -49.36% |
How will the commissioning of the Dahej-2 expansion in Q2 FY28 impact Sigachi's market share and pricing power in the global MCC segment?
What specific debottlenecking initiatives are planned to raise capacity utilization from 76.8% to support the aggressive full-year revenue guidance?
Will the launch of HiCel SMCC Nutra and the new CCS facility significantly diversify revenue away from the currently dominant MCC segment in the medium term?


































